Laurion Capital Management LP grew its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 195.8% in the 3rd quarter, HoldingsChannel reports. The fund owned 97,900 shares of the company’s stock after buying an additional 64,807 shares during the period. Laurion Capital Management LP’s holdings in Express Scripts were worth $9,301,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Acadian Asset Management LLC purchased a new stake in Express Scripts in the 2nd quarter worth approximately $314,000. Migdal Insurance & Financial Holdings Ltd. grew its stake in Express Scripts by 3,048.1% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock worth $126,000 after acquiring an additional 1,585 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its stake in Express Scripts by 44.7% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 32,125 shares of the company’s stock worth $2,480,000 after acquiring an additional 9,925 shares during the period. Adviser Investments LLC grew its stake in Express Scripts by 321.9% in the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after acquiring an additional 1,130 shares during the period. Finally, Alps Advisors Inc. grew its stake in Express Scripts by 10.5% in the 2nd quarter. Alps Advisors Inc. now owns 13,019 shares of the company’s stock worth $1,005,000 after acquiring an additional 1,238 shares during the period. 85.02% of the stock is owned by hedge funds and other institutional investors.

Shares of ESRX opened at $97.98 on Friday. The firm has a market capitalization of $55.75 billion, a price-to-earnings ratio of 13.80, a P/E/G ratio of 1.25 and a beta of 0.88. Express Scripts Holding Co has a fifty-two week low of $66.93 and a fifty-two week high of $101.73. The company has a current ratio of 0.77, a quick ratio of 0.65 and a debt-to-equity ratio of 0.63.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.42 by $0.01. The company had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. Express Scripts’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the business earned $2.51 EPS. Sell-side analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current fiscal year.

ESRX has been the subject of several recent analyst reports. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Credit Suisse Group cut shares of Express Scripts from an “outperform” rating to a “neutral” rating and lifted their target price for the stock from $90.00 to $96.50 in a research note on Tuesday, September 18th. Mizuho set a $101.00 target price on shares of Express Scripts and gave the stock a “hold” rating in a research note on Monday, November 5th. Finally, Royal Bank of Canada lifted their price target on shares of Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Express Scripts presently has an average rating of “Hold” and a consensus price target of $92.14.

In related news, Director Mahon Thomas P. Mac sold 5,234 shares of Express Scripts stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total transaction of $520,783.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.79% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/express-scripts-holding-co-esrx-position-raised-by-laurion-capital-management-lp/2667900.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Hedge Funds

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.